Invest India’s Ayush Roundtable Charts Path for Global Leadership in Traditional Medicine

New Delhi: In a groundbreaking roundtable conference organized by Invest India’s Ayush Strategic Policy and Facilitation Bureau, under the guidance of the Ministry of Ayush, key stakeholders unanimously asserted that Ayush, the traditional Indian system of medicine, is uniquely poised to become India’s soft power for the world. The event, held today at Vigyan Bhawan in Delhi, brought together industry leaders, policymakers, and experts to discuss the strategic growth and global impact of Ayush.

Vaidya Rajesh Kotecha, Secretary of the Ministry of Ayush, set an optimistic tone by acknowledging the sector’s growth, attributing it to the increasing number of entrepreneurs joining the field. He stressed the importance of Ayush expanding beyond wellness to therapeutic wellness and advocated for robust Pharmacovigilance systems to ensure product safety.

Highlighting India’s significant domestic market, Kotecha urged a focus on Medical Value Travel and the formulation of Ayush policies in specific states. He emphasized the abundance of skill sets, infrastructure, and teams within the Ayush sector, discussing various schemes and initiatives propelling the sector forward. The roundtable was noted for its role in uniting industry leaders from Ayush drug manufacturing companies, as well as sub-sectors like nutraceuticals and cosmeceuticals.

Dr. Tanuja Nesari, Director of AIIA, emphasized the global presence achieved through the establishment of the Global Center for Traditional Medicine (GCTM) and underscored the transformative potential of technology in traditional medicine practices.

Ms. Nivruti Rai, MD & CEO of Invest India, highlighted the concept of ‘glocal’: sourcing local, thinking, and selling globally. She emphasized the need for India to align with the vision of ‘Make in India’ and ‘Vocal for Local’ initiatives, expressing Invest India’s commitment to championing these initiatives for the Ayush sector.

The roundtable featured key figures from the Ayush sector, including Dr. Rabinarayan Acharya, DG of CCRAS, and Dr. Suruchi Mittar, Vice President of Invest India. Their expert insights enriched discussions on Ayush’s growth and global impact. The event facilitated a dynamic audience discussion, fostering diverse perspectives.

Dr. Suruchi Mittar delivered impactful closing remarks, summarizing key takeaways and reaffirming a commitment to advancing the Ayush sector. The roundtable aimed to explore investable opportunities, domestic and global regulations, awareness, trust, evidence acceptability, and better global market amplification and access.

The presence of CXOs and leadership from key Ayush sub-sectors showcased India and Ayush as the face of global health. The event emphasized the importance of investing in localized, high-quality supply chains, collaborating with global partners, and seeking global investment into the sector’s infrastructure and manpower, aligning with the vision of ‘Make In India’ and ‘Vocal for Local.’

The Invest India’s Ayush Strategic Policy and Facilitation Bureau played a pivotal role in facilitating the event, providing a platform for meaningful discussions, sharing best practices, and paving the way for global investments to strengthen and grow Ayush in India for the world.